Bayer CropScience Purchases Land Adjacent to its Research Triangle Park Headquarters

Acquired Parcel from Research Triangle Foundation Positions Company for Future Expansion

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
bayer cropscience
“With this newly acquired property, we now have flexibility to expand our business and continue to develop innovative agricultural technologies to feed a hungry planet,” said Jim Blome, president and CEO of Bayer CropScience LP.

RESEARCH TRIANGLE PARK, N.C. (PRWEB) December 20, 2012

Bayer CropScience LP today announced it has purchased nearly 70 acres of land located directly north of its current Research Triangle Park property at the intersection of T.W. Alexander Drive and North Carolina Highway 147 from the Research Triangle Foundation. This additional section of land provides the leading crop protection company the ability to expand its North American headquarters in the future.

“Bayer CropScience is committed to Research Triangle Park as its North American headquarters,” said Jim Blome, president and CEO of Bayer CropScience LP. “With this newly acquired property, we now have flexibility to expand our business and continue to develop innovative agricultural technologies to feed a hungry planet.”

In July, Bayer CropScience completed construction on a USD 20 million, 60,000 square-foot greenhouse, which is used for soy, corn and other broadacre crop research. In addition, the company recently announced plans to break ground in February on its North American Bee Care Center, a more than 6,600 square feet building in Research Triangle Park, which will serve as a gathering place for researchers, bee experts, students and other visitors to meet regularly with leading Bayer scientists.

The Research Triangle Foundation continues to see Bayer CropScience as an integral player in the growth and reputation of Research Triangle Park.

“Over the years, Bayer CropScience has played an important role in the Research Triangle Park’s research and development community,” said Bob Geolas, CEO of The Research Triangle Park. “The Foundation is happy to support Bayer as it continues to grow its presence and invest in the Park and what it stands for—innovation and economic growth. Biotech remains a focus for many of our companies here in RTP – and leaders like Bayer uphold our reputation as a R&D destination.”

###

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 7.255 billion (2011) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 21,000 and is represented in more than 120 countries. This and further news is available at: press.bayercropscience.com.

Contact:
Bayer CropScience Media Hotline, 1-877-879-6162, or

Becca Hogan
External Communications Manager
Bayer CropScience
Tel: (919) 549-2998
Email: becca(dot)hogan(at)bayer(dot)com

USA-BCS-2012-0523

Find more information at http://www.bayercropscience.us.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at http://www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.


Contact

Follow us on: Contact's Twitter